Zika Virus-Related Birth Defects and Neurological Complications: A Systematic Review and Meta-Analysis
1Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, China.
Reviews in Medical Virology
|March 4, 2025
Summary
Zika virus (ZIKV) infection during pregnancy significantly increases the risk of brain defects in newborns. Maternal age over 30 and ZIKV diagnosis after 25 weeks gestation are key risk factors for these Zika-associated birth defects.
Area of Science:
- Neuroscience
- Virology
- Public Health
Background:
- Zika virus (ZIKV) poses significant global health and economic challenges.
- Maternal ZIKV infection during pregnancy is linked to congenital anomalies and neurological issues in infants and adults.
Purpose of the Study:
- To systematically review and meta-analyze existing data on brain abnormalities in infants born to mothers infected with ZIKV during pregnancy.
- To identify specific brain defects and risk factors associated with ZIKV exposure in utero.
Main Methods:
- A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, and Embase up to November 2024.
- Included 14 studies involving 912 individuals, with critical appraisal using the Newcastle-Ottawa Scale.
- Performed subgroup analyses based on maternal age, gestational age, ZIKV diagnosis timing, sample type, and birth weight.
Main Results:
- The overall incidence of birth defects with brain abnormalities was 1.94 (95% CI: 1.3-2.7).
- Common brain abnormalities included microcephaly (OR: 2.7), ventriculomegaly (OR: 1.7), and corpus callosal anomaly (OR: 1.8).
- Maternal age ≥30 years and ZIKV diagnosis ≥25 weeks gestation were significant factors in Zika-associated birth defects.
Conclusions:
- This meta-analysis confirms a high risk of brain defects in infants exposed to ZIKV in utero.
- Maternal age and gestational timing of ZIKV diagnosis are crucial factors that may modify the risk of these congenital abnormalities.
More Related Videos
Related Concept Videos
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Neurulation
41.6K
Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
41.6K


